-

12:09:50 PM

MEDIF Stock News

MEDIF - Medipharm Labs Corp

03/01/23 7:30 AM

OTC : MEDIF

clinical trialfda approval

MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study

-MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, is pleased to provide an update on significant progress made in the field of cannabis research. MediPharm remains focused on investing in clinical research and supporting the development of future cannabis derived pharmaceutical drugs. MediPharm has been...

RHEA-AI

very positive

12/08/22 8:16 AM

OTC : MEDIF

MediPharm Labs Receives Award for CBD Brand of the Year

For the second year MediPharm Labs' pharma-quality CBD dominant oil line has been awarded the CBD Brand of the year by KIND Magazine. MediPharm Labs was also awarded the CBN Product of the Year and the Kindest Health and Wellness Brand of the Year Awards. MediPharm Labs' wellness products, lead by

RHEA-AI

neutral

11/14/22 7:00 AM

OTC : MEDIF

earnings

MediPharm Labs Reports Third Quarter Results

TORONTO , Nov. 14, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended September 30,

RHEA-AI

neutral

11/09/22 5:00 PM

OTC : MEDIF

conferencesearnings

MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results

BARRIE, ON , Nov. 9, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release second quarter financial results for the three and nine

RHEA-AI

neutral

10/07/22 7:00 AM

OTC : MEDIF

MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD

BARRIE, ON , Oct. 7, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, completed the sale of MediPharm Labs Australia Pty ("MediPharm Labs Australia"), a fully

RHEA-AI

neutral

08/15/22 7:00 AM

OTC : MEDIF

earnings

MediPharm Labs Reports Second Quarter Results

TORONTO , Aug. 15, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three and six months ended June 30,

RHEA-AI

neutral

08/11/22 7:00 AM

OTC : MEDIF

conferencesearnings

MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results

BARRIE, ON , Aug. 11, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release second quarter financial results for the three and six

RHEA-AI

neutral

08/09/22 7:00 AM

OTC : MEDIF

MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC

MediPharm to design, manufacture and supply a liquid oral cannabis study drug for the Phase 2 Life's end Benefits of cannabidiol and tetrahydrocannabinol (LiBBY) study, to be conducted in the U.S., across 20 sites. The lead investigators have been awarded a total of US$16M grant from the US

RHEA-AI

neutral

07/27/22 7:00 AM

OTC : MEDIF

MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous Customer

BARRIE, ON , July 27, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced that it has been awarded a favourable summary of judgement in

RHEA-AI

neutral

07/11/22 7:00 AM

OTC : MEDIF

MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility

BARRIE, ON, July 11, 2022 - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, has entered into a Share Purchase Agreement (the "Agreement") with OneLife Botanicals PTY

RHEA-AI

very positive

1 2 3 4 5 6 Next